A Single Dose Study to Investigate the Pharmacokinetics of MK4305 in Patients With Hepatic Insufficiency.

Trial Profile

A Single Dose Study to Investigate the Pharmacokinetics of MK4305 in Patients With Hepatic Insufficiency.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Jul 2017

At a glance

  • Drugs Suvorexant (Primary)
  • Indications Insomnia
  • Focus Pharmacokinetics
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 26 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 May 2010 Planned end date changed from 1 Apr 2010 to 1 Jun 2010 as reported by ClinicalTrials.gov.
    • 18 Feb 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top